Latest market price
6.14
-0.16-2.54%
OverviewShort InterestFilings
AURAQT35Aura Biosciences, Inc.·NASDAQ
6.14-2.54%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13GBeneficial ownership statement (passive)
Oct 01, 2026SC 13GBeneficial ownership statement (passive)
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 2026S-8Registration of employee benefit securities
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Aug 20, 2026EFFECTNotice of effectiveness
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20263Initial statement of beneficial ownership
Aug 12, 20263Initial statement of beneficial ownership
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20263Initial statement of beneficial ownership
Aug 11, 202610-QQuarterly report
Aug 11, 2026S-3Shelf registration statement
Aug 11, 20268-KCurrent report
Aug 05, 20268-KCurrent report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 08, 20263Initial statement of beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 365
Page
▼
/ 15